Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Clinical trial NCT01576666 · COMPLETED

Trial details

NCT number: NCT01576666
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dose Escalation Safety Preliminary Efficacy Advanced Solid Tumors Metastatic Breast Cancer Advanced Pancreatic Adenocarcinoma Metastatic Colorectal Cancer Recurrent Glioblastoma Multiforme Gastric Cancer Gastroesophageal Junction Cancer Triple Negative Metastatic Breast Cancer Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer

Start date: 2012-07-01
Primary completion: 2015-04-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.